Modified FOLFIRINOX versus S-1 as second-line chemotherapy in patients with gemcitabine-failed metastatic pancreatic cancer: A randomized phase III trial (MPACA-3).

Go, Se-Il; Lee, Sang-Cheol; Bae, Woo Kyun; Zang, Dae Young; Lee, Hyun Woo; Jang, Joung Soon; Ji, Jun Ho; Kim, Jung Hoon; Park, Sanggon; Sym, Sun Jin; Yang, Yaewon; Jeon, So Yeon; Oh, Sung Yong; Kang, Jung Hun

doi:10.1200/JCO.2021.39.15_suppl.4119

Detailed Information

Cited 0 time in webofscience

Cited 0 time in scopus

Metadata Downloads

Modified FOLFIRINOX versus S-1 as second-line chemotherapy in patients with gemcitabine-failed metastatic pancreatic cancer: A randomized phase III trial (MPACA-3).

Authors: Go, Se-Il; Lee, Sang-Cheol; Bae, Woo Kyun; Zang, Dae Young; Lee, Hyun Woo; Jang, Joung Soon; Ji, Jun Ho; Kim, Jung Hoon; Park, Sanggon; Sym, Sun Jin; Yang, Yaewon; Jeon, So Yeon; Oh, Sung Yong; Kang, Jung Hun

Issue Date: May-2021

Publisher: LIPPINCOTT WILLIAMS & WILKINS

Citation: JOURNAL OF CLINICAL ONCOLOGY, v.39, no.15

Journal Title: JOURNAL OF CLINICAL ONCOLOGY

Volume: 39

Number: 15

URI: https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/54519

DOI: 10.1200/JCO.2021.39.15_suppl.4119

ISSN: 0732-183X
1527-7755

Files in This Item: There are no files associated with this item.

Appears in Collections: College of Medicine > College of Medicine > 1. Journal Articles

Show full item record

qrcode

Altmetrics

Total Views & Downloads

STATISTICS: Total View :7,449,702; Today View :34

RSS_1.0 RSS_2.0 ATOM_1.0

84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Altmetrics

Total Views & Downloads

BROWSE